Extracting Breast Cancer Phenotypes from Clinical Notes: Comparing LLMs with Classical Ontology Methods
arXiv:2604.06208v1 Announce Type: new Abstract: A significant amount of data held in Oncology Electronic Medical Records (EMRs) is contained in unstructured provider notes -- including but not limited to the chemotherapy (or cancer treatment) outcome, different biomarkers, the tumor's location, sizes, and growth patterns of a patient. The clinical studies show that the majority of oncologists are comfortable providing these valuable insights in their notes in a natural language rather than the relevant structured fields of an EMR. The major contribution of this research is to report an LLM-based framework to process provider notes and extract valuable medical knowledge and phenotype mentioned above, with a focus on the domain of oncology. In this paper, we focus on extracting phenotypes related to breast cancer using our LLM framework, and then compare its performance with earlier works that used knowledge-driven annotation system, paired with the NCIt Ontology Annotator. The results
arXiv:2604.06208v1 Announce Type: new Abstract: A significant amount of data held in Oncology Electronic Medical Records (EMRs) is contained in unstructured provider notes -- including but not limited to the chemotherapy (or cancer treatment) outcome, different biomarkers, the tumor's location, sizes, and growth patterns of a patient. The clinical studies show that the majority of oncologists are comfortable providing these valuable insights in their notes in a natural language rather than the relevant structured fields of an EMR. The major contribution of this research is to report an LLM-based framework to process provider notes and extract valuable medical knowledge and phenotype mentioned above, with a focus on the domain of oncology. In this paper, we focus on extracting phenotypes related to breast cancer using our LLM framework, and then compare its performance with earlier works that used knowledge-driven annotation system, paired with the NCIt Ontology Annotator. The results of the study show that an LLM-based information extraction framework can be easily adapted to extract phenotypes with an accuracy that is comparable to the classical ontology-based methods. However, once trained, they could be easily fine-tuned to cater for other cancer types and diseases.
Executive Summary
This article explores the efficacy of Large Language Models (LLMs) in extracting critical breast cancer phenotypes from unstructured clinical notes within Electronic Medical Records (EMRs). The research posits an LLM-based framework to address the prevalent issue of vital oncology data being recorded in natural language, rather than structured fields. By comparing its performance against classical ontology-based methods, specifically the NCIt Ontology Annotator, the study demonstrates that LLMs achieve comparable accuracy. A key finding is the adaptability and fine-tuning potential of LLMs for various cancer types and diseases, suggesting a scalable solution for medical knowledge extraction, with significant implications for clinical research and personalized medicine.
Key Points
- ▸ Unstructured clinical notes contain substantial, valuable oncology data (biomarkers, tumor characteristics, treatment outcomes).
- ▸ LLM-based framework developed for extracting breast cancer phenotypes from provider notes.
- ▸ Performance of the LLM framework is comparable to classical ontology-based methods (NCIt Ontology Annotator).
- ▸ LLMs offer significant adaptability and fine-tuning potential for other cancer types and diseases.
- ▸ The study highlights the potential for LLMs to bridge the gap between natural language documentation and structured data utilization in EMRs.
Merits
Addresses a Critical Data Challenge
Effectively tackles the persistent problem of extracting actionable intelligence from unstructured clinical narratives, a major bottleneck in EMR utility.
Direct Comparative Analysis
Provides a valuable head-to-head comparison of LLM performance against established, classical ontology methods, lending credibility to its findings.
Demonstrates Scalability Potential
Highlights the 'easily fine-tuned' aspect, suggesting a significant advantage in adapting the framework across diverse disease domains beyond breast cancer.
Practical Application Focus
The research is clearly oriented towards a real-world clinical problem, offering a tangible solution for improving data accessibility for research and care.
Demerits
Limited Scope of Comparison
While comparing to NCIt is good, the article could benefit from a broader discussion of other advanced NLP techniques or hybrid approaches for a more comprehensive benchmark.
Absence of Specific Performance Metrics
The abstract states 'comparable accuracy' without quantifying it (e.g., F1-score, precision, recall), making it difficult to fully assess the practical equivalence.
Lack of Details on LLM Architecture and Training
The abstract does not provide insight into the specific LLM model used, the training data size, or the fine-tuning methodology, which are crucial for reproducibility and deeper analysis.
Ethical and Privacy Considerations Underexplored
Given the sensitive nature of clinical notes, the abstract does not touch upon data anonymization, privacy protection, or potential biases inherent in LLM training, which are critical in a healthcare context.
Expert Commentary
The article presents a compelling case for the utility of LLMs in a domain long challenged by data fragmentation: the extraction of clinical insights from unstructured notes. The demonstrated 'comparable accuracy' against established ontology methods is a significant validation, suggesting that the formidable linguistic capabilities of LLMs can indeed unlock previously inaccessible data at scale. The emphasis on adaptability across cancer types underscores a crucial advantage over rule-based or highly specialized NLP systems, promising a more generalizable and cost-effective solution. However, the abstract's brevity regarding specific performance metrics, the LLM architecture, and training details leaves critical gaps for a full scholarly evaluation. Future iterations must address these methodological specifics and, crucially, delve into the ethical dimensions of deploying such powerful AI in sensitive clinical contexts, particularly regarding data privacy, bias mitigation, and the imperative for clinical interpretability. This work lays a strong foundation, but the journey from 'comparable' to 'clinically indispensable' requires rigorous transparency and thoughtful engagement with broader medico-legal implications.
Recommendations
- ✓ Publish full methodological details, including specific LLM architecture, training data characteristics, and hyper-parameters, to ensure reproducibility and facilitate further research.
- ✓ Provide quantitative performance metrics (e.g., F1-score, precision, recall, AUC) for both the LLM and the baseline ontology method to allow for a precise comparison of efficacy.
- ✓ Include a dedicated section on ethical considerations, detailing data anonymization techniques, bias assessment, and strategies for ensuring patient data privacy and security.
- ✓ Explore the interpretability of the LLM's extractions, perhaps through attention mechanisms or saliency maps, to provide clinicians with insights into *why* a particular phenotype was identified.
- ✓ Discuss the potential for hybrid models that combine the strengths of LLMs with the precision and explainability of classical rule-based or ontology-driven systems.
Sources
Original: arXiv - cs.CL